Evidence map›Paper›PMID 33772746›Full record

ArticleEndocrine2021

Assessing potential impact of 2015 American Thyroid Association guidelines on community standard practice for I-131 treatment of low-risk differentiated thyroid cancer: case study of Jordan.

Malik E Juweid, Nidal J Rabadi, Mark Tulchinsky, Mohammed Aloqaily, Ahmad Al-Momani, Majd Arabiat, Gassem Abu Ain, Hussam Al Hawari, Munther Al-Momani, Ayman Mismar and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Malik E JuweidDivision of Nuclear Medicine/Department of Radiology and Nuclear Medicine, University of Jordan, Amman, Jordan.
Nidal J RabadiDivision of Nuclear Medicine/Department of Radiology and Nuclear Medicine, University of Jordan, Amman, Jordan.
Mark TulchinskyDepartment of Radiology, Penn State Health, Hershey, PA, USA. Mark.Tulchinsky@Gmail.com.ORCID 0000-0002-6848-0878
Mohammed AloqailyDivision of Nuclear Medicine/Department of Radiology and Nuclear Medicine, University of Jordan, Amman, Jordan.
Ahmad Al-MomaniDivision of Nuclear Medicine/Department of Radiology and Nuclear Medicine, University of Jordan, Amman, Jordan.
Majd ArabiatDivision of Endocrinology, Department of Medicine, University of Jordan, Amman, Jordan.
Gassem Abu AinDivision of Nuclear Medicine/Department of Radiology and Nuclear Medicine, University of Jordan, Amman, Jordan.
Hussam Al HawariDivision of Endocrinology, Department of Medicine, University of Jordan, Amman, Jordan.
Munther Al-MomaniDivision of Endocrinology, Department of Medicine, University of Jordan, Amman, Jordan.
Ayman MismarDepartment of Special Surgery, University of Jordan, Amman, Jordan.
Amr AbulabanDivision of Nuclear Medicine/Department of Radiology and Nuclear Medicine, University of Jordan, Amman, Jordan.
Ibrahim TahaDivision of Nuclear Medicine/Department of Radiology and Nuclear Medicine, University of Jordan, Amman, Jordan.
Abdullah AlhouriDivision of Nuclear Medicine/Department of Radiology and Nuclear Medicine, University of Jordan, Amman, Jordan.
Ayman ZayedDivision of Endocrinology, Department of Medicine, University of Jordan, Amman, Jordan.
Nader AlbsoulDepartment of Special Surgery, University of Jordan, Amman, Jordan.
Mousa A Al-AbbadiDepartment of Histopathology, Microbiology and Forensic Medicine, University of Jordan, Amman, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe 2015 American Thyroid Association (ATA) guidelines called for significantly more selective

methodsAll DTC patients managed at Jordan University Hospital (JUH) between 1/2009 and 6/2019 were classified according to the 2015 ATA risk category and

resultsIn total, 135/182 DTC patients (74.2%) managed at JUH underwent

conclusionThis study demonstrates a significant reduction in

Indexed as

Adenocarcinoma, FollicularThyroid NeoplasmsHumansIodine RadioisotopesJordanThyroidectomyUnited StatesIodine-131Iodine RadioisotopesDifferentiated thyroid cancer (DTC)High-risk DTC.I-131 therapyIntermediate-risk DTCLow-risk DTC

Identifiers

PMID33772746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.